Distribution of beta-lactamase genes in Enterobacteriaceae from human clinical samples

IF 2.9 4区 医学 Q2 INFECTIOUS DISEASES Infectious diseases now Pub Date : 2025-02-01 DOI:10.1016/j.idnow.2024.105019
Md.Kaisar Rahman, Babafela Awosile
{"title":"Distribution of beta-lactamase genes in Enterobacteriaceae from human clinical samples","authors":"Md.Kaisar Rahman,&nbsp;Babafela Awosile","doi":"10.1016/j.idnow.2024.105019","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to explore the distribution of beta-lactamase genes in Enterobacteriaceae from human clinical samples.</div></div><div><h3>Methods</h3><div>We analyzed data from 83 countries through the Antimicrobial Testing Leadership and Surveillance program, spanning 2004 to 2021. We calculated the proportion of each β-lactamase gene across nine bacterial species and generated a heatmap for β-lactamase genes with a frequency of ≥ 1 % in at least one species.</div></div><div><h3>Results</h3><div>A total of 359 β-lactamase genes were identified, with the highest proportion found in <em>Klebsiella</em> spp. (61.84 %, n = 222), followed by <em>Escherichia<!--> <!-->coli</em> (47.63 %, n = 171), and <em>Proteus</em> spp. (20.61 %, n = 74). The ESBL gene <em>bla</em><sub>CTX-M−15</sub> was most prevalent in <em>Klebsiella</em> spp. (62.39 %) and <em>E.<!--> <!-->coli</em> (53.16 %). The carbapenemase genes <em>bla</em><sub>NDM-1</sub>, <em>bla</em><sub>OXA-48</sub>, and <em>bla</em><sub>KPC-2</sub> were notably higher in <em>Providencia</em> spp. (59.47 %), <em>Raoultella</em> spp. (45.45 %), and <em>Serratia</em> spp. (25.24 %), respectively.</div></div><div><h3>Conclusion</h3><div>Further surveillance and research are needed to investigate the diversity of β-lactamase genes across One Health interfaces.</div></div>","PeriodicalId":13539,"journal":{"name":"Infectious diseases now","volume":"55 1","pages":"Article 105019"},"PeriodicalIF":2.9000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases now","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666991924001866","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

This study aimed to explore the distribution of beta-lactamase genes in Enterobacteriaceae from human clinical samples.

Methods

We analyzed data from 83 countries through the Antimicrobial Testing Leadership and Surveillance program, spanning 2004 to 2021. We calculated the proportion of each β-lactamase gene across nine bacterial species and generated a heatmap for β-lactamase genes with a frequency of ≥ 1 % in at least one species.

Results

A total of 359 β-lactamase genes were identified, with the highest proportion found in Klebsiella spp. (61.84 %, n = 222), followed by Escherichia coli (47.63 %, n = 171), and Proteus spp. (20.61 %, n = 74). The ESBL gene blaCTX-M−15 was most prevalent in Klebsiella spp. (62.39 %) and E. coli (53.16 %). The carbapenemase genes blaNDM-1, blaOXA-48, and blaKPC-2 were notably higher in Providencia spp. (59.47 %), Raoultella spp. (45.45 %), and Serratia spp. (25.24 %), respectively.

Conclusion

Further surveillance and research are needed to investigate the diversity of β-lactamase genes across One Health interfaces.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人临床肠杆菌科β -内酰胺酶基因的分布。
背景:本研究旨在探讨肠杆菌科人类临床样本中β -内酰胺酶基因的分布。方法:我们通过抗微生物检测领导和监测项目分析了2004年至2021年83个国家的数据。我们计算了9种细菌中每个β-内酰胺酶基因的比例,并生成了至少一个物种中频率为 ≥ 1 %的β-内酰胺酶基因热图。结果:共有359β内酰胺酶基因被确定,最高的比例在克雷伯氏菌spp。(61.84 % n = 222),其次是Escherichiacoli(47.63 % n = 171),和变形杆菌spp。(20.61 % n = 74)。ESBL基因blaCTX-M-15在克雷伯氏菌(62.39 %)和大肠杆菌(53.16 %)中最常见。碳青霉烯酶基因blaNDM-1、blaOXA-48和blaKPC-2在普罗维登氏菌(59.47 %)、拉乌尔氏菌(45.45 %)和塞拉氏菌(25.24 %)中表达量显著高于其他基因。结论:β-内酰胺酶基因的多样性有待于进一步的监测和研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Infectious diseases now
Infectious diseases now Medicine-Infectious Diseases
CiteScore
7.10
自引率
2.90%
发文量
116
审稿时长
40 days
期刊最新文献
Clinical, biological, metabolic, and immune changes associated with the use of sodium-glucose cotransporter 2 inhibitors in people living with HIV Culture yield of 1st and 2nd biopsy in bacterial non-mycobacterial spondylodiscitis in a university hospital Impact of an antimicrobial stewardship program on the appropriate use of carbapenems in a French university hospital (CARBACAI study) Partner treatment strategies for Chlamydia and Gonorrhea: Time for a reappraisal Comment on “Delta and Omicron SARS-CoV-2 pneumonia: Comparison of clinical and radiological features”
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1